Table of Contents
Volume 8 | Supplement 2
Publication Date: February 2007- Abstract
- No Access
- Pay-Per View
- Full Text
- Add to Cart
Introduction | ||
S50-S51 |
Second-Generation Tyrosine Kinase Inhibitors in Non–Small-Cell Lung Cancer Roy S. Herbst |
|
Contributions | ||
S52-S60 |
Key Signaling Pathways and Targets in Lung Cancer Therapy Nicholas W. Choong, Ravi Salgia, Everett E. Vokes |
|
S61-S67 |
Epidermal Growth Factor Receptor Inhibitors plus Chemotherapy in Non–Small-Cell Lung Cancer: Biologic Rationale for Combination Strategies David R. Gandara, Angela M. Davies, Oliver Gautschi, Philip C. Mack, Derick H. Lau, Primo N. Lara Jr, Fred R. Hirsch |
|
S68-S73 |
Chemotherapy and Antiangiogenic Agents in Non–Small-Cell Lung Cancer Leora Horn, Alan Sandler |
|
S74-S78 |
Novel Small-Molecule Inhibitors of the Vascular Endothelial Growth Factor Receptor Alex A. Adjei |
|
S79-S85 |
Dual Targeting of the Vascular Endothelial Growth Factor and Epidermal Growth Factor Receptor Pathways: Rationale and Clinical Applications for Non–Small-Cell Lung Cancer Lauren A. Byers, John V. Heymach |
|